Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 6, 2000

View Archived Issues

Tibolone improves auditory function in postmenopausal women

FDA informs Urologix of new developments concerning the Targis System

Apo A-IV peptide suppresses appetite in obese rats, offered for licensing

AstraZeneca explores novel strategy for treating diabetes and certain other disorders

NPY receptor antagonists with dihydropyridine structure disclosed by Bristol-Myers Squibb

Atridox periodontal therapy approved in E.U.

New series of NOS inhibitors in early development at Pfizer

Imidazole cytokine inhibitors in the pipeline at SmithKline Beecham

Zambon and Sheffield begin clinical program for MSI-ipratropium

New thrombin inhibitors presented by Merck & Co. research group

Orally active, selective iNOS inhibitors discovered at Glaxo Wellcome

Protein-tyrosine-phosphatases explored at AHP as novel target for diabetes Rx

New developments announced for AltaRex's ovarian cancer therapy

Glaxo discovers PPARgamma agonist with excellent pharmacological and pharmacokinetic profile

Medarex antibody therapy reduces inflammation in vivo

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 9, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...